Triple-negative breast cancer has unique characteristics that may limit treatment options. In this video, learn what therapies and medications work to treat this subtype of breast cancer, according to Amy Tiersten, MD, Oncologist and Hematologist at Dubin Breast Center at Mount Sinai Hospital in New York City.
Amy Tiersten, MD, is a Professor of Medicine, Hematology, and Medical Oncology at the Icahn School of Medicine at Mount Sinai. She sees patients at the Dubin Breast Center.
References
Anders, C. K., et al. (2023). ER/PR negative, HER2-negative (triple-negative) breast cancer. UpToDate.
Centers for Disease Control and Prevention. (2022). What is triple-negative breast cancer?
National Breast Cancer Foundation, Inc. (2020). Triple negative breast cancer.
Susan G. Komen Foundation. (2023). Triple negative breast cancer.
Why trust our experts?
